t must submit a premarket notification to FDA. FDA reviews
these notifications to determine if the new device is &quot;substantially equivalent&quot;
to a device that was marketed prior to passage of the Amendments (i.e., a
&quot;pre-amendments device&quot;). If the new device is deemed substantially equivalent
to a pre-amendments device, it may be marketed immediately and is regulated in the same
regulatory class as the pre-amendments device to which it is equivalent. (The premarket
notification requ